Unicycive Therapeutics (UNCY) Competitors

Unicycive Therapeutics (NASDAQ:UNCY) and Cryoport (NASDAQ:CYRX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, valuation, risk, media sentiment and community ranking.

Which has more risk and volatility, UNCY or CYRX?

Unicycive Therapeutics has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500. Comparatively, Cryoport has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500.

Which has better earnings & valuation, UNCY or CYRX?

Unicycive Therapeutics has higher earnings, but lower revenue than Cryoport. Cryoport is trading at a lower price-to-earnings ratio than Unicycive Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Unicycive Therapeutics	$680K	105.67	-$30.54M	-$1.07	-0.56
Cryoport	$228.39M	1.21	-$99.59M	-$2.49	-2.23

Do insiders and institutionals hold more shares of UNCY or CYRX?

40.4% of Unicycive Therapeutics shares are held by institutional investors. Comparatively, 92.9% of Cryoport shares are held by institutional investors. 24.1% of Unicycive Therapeutics shares are held by company insiders. Comparatively, 10.1% of Cryoport shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media prefer UNCY or CYRX?

In the previous week, Cryoport had 6 more articles in the media than Unicycive Therapeutics. MarketBeat recorded 9 mentions for Cryoport and 3 mentions for Unicycive Therapeutics. Cryoport's average media sentiment score of 0.63 beat Unicycive Therapeutics' score of 0.15 indicating that Cryoport is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Unicycive Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cryoport	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer UNCY or CYRX?

Unicycive Therapeutics currently has a consensus target price of $5.25, suggesting a potential upside of 774.56%. Cryoport has a consensus target price of $11.67, suggesting a potential upside of 110.21%. Given Unicycive Therapeutics' stronger consensus rating and higher possible upside, research analysts plainly believe Unicycive Therapeutics is more favorable than Cryoport.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Unicycive Therapeutics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
Cryoport	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Is UNCY or CYRX more profitable?

Unicycive Therapeutics has a net margin of 0.00% compared to Cryoport's net margin of -70.08%. Unicycive Therapeutics' return on equity of 0.00% beat Cryoport's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Unicycive Therapeutics	N/A	N/A	-29.88%
Cryoport	-70.08%	-13.35%	-6.43%

Does the MarketBeat Community believe in UNCY or CYRX?

Cryoport received 217 more outperform votes than Unicycive Therapeutics when rated by MarketBeat users. However, 77.27% of users gave Unicycive Therapeutics an outperform vote while only 65.88% of users gave Cryoport an outperform vote.

Company	Underperform	Outperform
Unicycive Therapeutics	Outperform Votes 34 77.27%	Underperform Votes 10 22.73%
Cryoport	Outperform Votes 251 65.88%	Underperform Votes 130 34.12%

Summary

Unicycive Therapeutics beats Cryoport on 12 of the 19 factors compared between the two stocks.